 BELGRADE, Mont., Feb. 22, 2021 GLOBE NEWSWIRE -- Xtant Medical Holdings, Inc. NYSE American: XTNT the Company, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it has entered into a definitive agreement with a single healthcare-focused institutional investor in a private placement of 8,888,890 common shares and warrants to purchase 6,666,668 common shares at a combined purchase price of 2.25 per share for gross proceeds of approximately 20 million before deducting fees and other estimated offering expenses. The warrants will have an exercise price of 2.25 per share, will be immediately exercisable and will expire five years from the date of issuance. 